Research

submenu

Current CNBD Research Studies

Below is a list of current CNBD research studies. Subject tags will link you to study listings by topic. 

Developmental period: Prenatal, Infancy, Childhood, Adolescence

Perturbation: Substance Use/ Abuse, Nutrition/MalnutritionGenetic/Congenital/Developmental Disorder, Prematurity, Social/Emotional DevelopmentBehavioral DevelopmentCognitive Development/DelayInstitutional Neglect/Deprivation

Research tools: Electrophysiology, Imaging, Autonomic System, Body Composition, CANTAB, TOVA, Eyetracker, Epigenetics

 

A Longitudinal Study Examining Three RDoC Constructs in Adolescents with Non-Suicidal Self-Injury

Principal Investigator:

Kathryn Cullen, MD (Department of Psychiatry)

[+/-] Show/Hide Collaborators & Abstract

A Marker Task of Amygdala Function in Preschool Aged Children

Principal Investigator:

Jed Elison, PhD (Institute of Child Development and Department of Pediatrics)

 

[+/-] Show/Hide Collaborators & Abstract

A Multi-center, Randomized, Double-blind, 12-week, Parallel Group, Placebo-controlled Proof of Concept Study to Investigate the Efficacy and Safety of RO5285119 in Individuals with Autism Spectrum Disorders (ASD)

Principal Investigator:

Suma Jacob, MD, PhD (Department of Psychiatry)

[+/-] Show/Hide Abstract

A Phase I, Multicenter, Open-label, Single-dose, Dose Ranging Study to Assess the Safety and Tolerability of SB-318, a rAAV2/6-based Gene Transfer in Subjects with Mucopolysaccharidosis I (MPS I)

Principal Investigator:

Chester B. Whitley PhD, MD (Department of Pediatrics)

[+/-] Show/Hide Collaborators & Abstract

A Phase II Multi-center, Randomized, Doubleblind, 24-Week, 3-ARM, Parallel Group, Placebo-controlled Study to Investigate the Efficacy and Safety of RO5285119 in Children and Adolescents Age 5-17 With Autism Spectrum Disorder (ASD)

Principal Investigator:

Suma Jacob, MD, PhD (Department of Psychiatry)

[+/-] Show/Hide Collaborators & Abstract

A Phase II/III Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously

Principal Investigator:

Chester Whitley, M.D., Ph.D. (Department of Pediatrics)

[+/-] Show/Hide Collaborators & Abstract

A prospective, observational, single-center study of the effects of illness and nutrition on growth and cognition in AGA VLBW preterm infants

Principal Investigator:

Sara Ramel, MD (Department of Pediatrics)

[+/-] Show/Hide Collaborators & Abstract

A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of HGT-1410 (Recombinant Human Heparan N-Sulfatase) Administration via an Intrathecal Drug Delivery Device in Pediatric Patients with Early Stage Mucopolysaccharidosis

Principal Investigator:

Chester B. Whitley PhD, MD (Department of Pediatrics)

[+/-] Show/Hide Collaborators & Abstract

A study of intrathecal enzyme replacement for cognitive decline in Mucopolysaccharidosis I

Principal Investigator:

Julie Eisengart, PhD, LP (Department of Pediatrics)

[+/-] Show/Hide Collaborators & Abstract

Assessment of body composition in infants with cystic fibrosis

Principal Investigator:

Elissa M. Downs, MD, MPH (Pediatric Gastroenterology, Hepatology, and Nutrition)

[+/-] Show/Hide Collaborators & Abstract

Pages